Vyzulta Deep Dive: What Makes It Different in Glaucoma Care

What makes Vyzulta different from other glaucoma drops?
In this Vyzulta Deep Dive, Dr. Constance Okeke breaks down the dual mechanism of action—prostaglandin + nitric oxide—and explain why this matters for trabecular meshwork function and IOP control.

This video is part of the AGE (Advocates for Glaucoma Education) Initiative.
This video is sponsored by Bausch + Lomb.

You’ll learn:
✔ How nitric oxide enhances conventional outflow
✔ How Vyzulta compares to traditional prostaglandins
✔ Key findings from clinical trials including up to 7–9 mmHg reduction
✔ Real-world outcomes from my own investigator studies
✔ Where Vyzulta fits into first-line therapy and switching strategies
✔ A practical case example demonstrating impact on IOP

If you manage glaucoma patients, this is a must-watch overview of a drop with a truly unique MOA.

📘 Additional Resources
👉 Get the Glaucoma Medication Guide which includes a comprehensive list of the most commonly used glaucoma drops, descriptions of mechanisms of action, dosages, common adverse effects, and efficacy. Download here: https://mailchi.mp/b7dec1ed14a3/zbxbz...
👉 Watch the extended case examples video: “Vyzulta Real-World Study Results”:    • Choosing VYZULTA for newly diagnosed and/o...  
👉 For more glaucoma education, subscribe to the ‪@iGlaucoma‬ Channel

#Vyzulta, #GlaucomaCare, #EyePressure, #Ophthalmology, #Optometry, #GlaucomaEducation, #NitricOxide, #BauschAndLomb, #AGEInitiative, #iGlaucoma, #GlaucomaTreatment, #GlaucomaDrops, #EyeHealth